U.S. Makes Initial Offers in Medicare Drug Price Negotiationsnews2024-02-01T18:36:19+00:00February 1st, 2024|The New York Times|
Medicare Open Enrollment Is Starting. Here’s How to Navigate the Ad Blitz.news2023-10-14T09:01:47+00:00October 14th, 2023|The New York Times|
Biden Administration Unveils First Drugs for Medicare Price Negotiationsnews2023-08-29T22:50:39+00:00August 29th, 2023|The New York Times|
New RSV Vaccines Aren’t Covered by Some Health Insurance Plansnews2023-08-25T19:55:21+00:00August 25th, 2023|The New York Times|
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiationsnews2023-07-23T07:00:18+00:00July 23rd, 2023|The New York Times|
FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
FDA Approves, Leqembi, New Treatment for Early Alzheimer’snews2023-01-06T22:58:48+00:00January 6th, 2023|The New York Times|
What the Biden Administration Could Do Now to Protect Abortion Rightsnews2022-07-08T23:40:08+00:00July 8th, 2022|The New York Times|
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trialsnews2022-04-07T23:32:59+00:00April 7th, 2022|The New York Times|
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drugnews2022-04-06T18:43:00+00:00April 6th, 2022|The New York Times|